Vimarsana
Biggest News Aggregation in the World

Page 9 - Next Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Next Test Today - Breaking & Trending Today

Guardant Health (NASDAQ:GH) Stock Price Up 4.9% - Vimarsana News

Guardant Health (NASDAQ:GH) Stock Price Up 4.9%

Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) were up 4.9% during mid-day trading on Friday . The company traded as high as $37.65 and last traded at $37.30. Approximately 403,301 shares traded hands during trading, a decline of 79% from the average daily volume of 1,921,296 shares. The stock had previously closed […]

Source: wkrb13.com
Guardant Health (NASDAQ:GH) Trading Up 4.9% - Vimarsana News

Guardant Health (NASDAQ:GH) Trading Up 4.9%

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) was up 4.9% during mid-day trading on Friday . The stock traded as high as $37.65 and last traded at $37.30. Approximately 403,301 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 1,921,296 shares. The stock had previously closed at […]

SWS Partners Boosts Position in Guardant Health, Inc. (NASDAQ:GH) - Vimarsana News

SWS Partners Boosts Position in Guardant Health, Inc. (NASDAQ:GH)

SWS Partners raised its stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) by 8.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,492 shares of the company’s stock after buying an additional 3,391 shares during the period. SWS Partners’ […]

Guardant Health (NASDAQ:GH) Given New $55.00 Price Target at Morgan Stanley - Vimarsana News

Guardant Health (NASDAQ:GH) Given New $55.00 Price Target at Morgan Stanley

Guardant Health (NASDAQ:GH – Get Free Report) had its price objective cut by equities researchers at Morgan Stanley from $60.00 to $55.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of […]

Source: wkrb13.com
Citigroup Boosts Guardant Health (NASDAQ:GH) Price Target to $50.00 - Vimarsana News

Citigroup Boosts Guardant Health (NASDAQ:GH) Price Target to $50.00

Guardant Health (NASDAQ:GH – Free Report) had its price objective upped by Citigroup from $40.00 to $50.00 in a research note released on Friday morning, MarketBeat reports. The brokerage currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. Piper Sandler lowered their price target […]